Publicaciones (54) Publicaciones de JOSE LUIS MORALES RULL

2024

  1. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports

  2. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  3. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure

    ESC Heart Failure, Vol. 11, Núm. 3, pp. 1767-1776

  4. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

    The Lancet Microbe, Vol. 5, Núm. 6, pp. e559-e569

  5. Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial

    Revista Clinica Espanola, Vol. 224, Núm. 2, pp. 67-76

  6. The significance of metabolic alkalosis on acute decompensated heart failure: the ALCALOTIC study

    Clinical Research in Cardiology

2023

  1. Combination diuretic therapy in acute heart failure

    European Heart Journal

  2. Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post-hoc analysis of the CLOROTIC trial

    European Journal of Heart Failure, Vol. 25, Núm. 10, pp. 1784-1793

  3. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

    European heart journal, Vol. 44, Núm. 5, pp. 411-421

  4. Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure—Barriers and Opportunities for Improvement: The PREVAMIC Study

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  5. Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure

    Revista Clinica Espanola, Vol. 223, Núm. 8, pp. 499-509

  6. “Optimal recovery” after colon cancer surgery in the elderly, a comparative cohort study: Conventional care vs. enhanced recovery vs. prehabilitation

    Cirugia Espanola, Vol. 101, Núm. 6, pp. 426-434

2022

  1. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 5, pp. 622-635

  2. Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain

    Global Epidemiology, Vol. 4

  3. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

    The Lancet, Vol. 399, Núm. 10324, pp. 530-540

  4. Prognostic Significance of the PROFUND Index on One Year Mortality in Acute Heart Failure: Results from the RICA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  5. The EPICTER score: a bedside and easy tool to predict mortality at 6 months in acute heart failure

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2348-2356

  6. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

    The Lancet Respiratory Medicine, Vol. 10, Núm. 10, pp. 972-984

2021

  1. Consensus on basic conduct during the hospital admission of patients with acute heart failure

    Revista Clinica Espanola, Vol. 221, Núm. 5, pp. 283-296

  2. Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4820-4831